Asarina Pharma Company

Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders.
Industry: General Healthcare
Headquarters: Solna, Stockholms Lan, Sweden
Founded Date: 01-01-2006
Employees Number: 1-10
Funding Status: IPO
Investors Number: 4
Total Funding: $24,828,814
Estimated Revenue: Less than $1M
Last Funding Date: 2018-09-20
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership